Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE vs GILTERITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMCITABINE vs GILTERITINIB: Safety Overview

Metric GEMCITABINE GILTERITINIB
Total FAERS Reports 31,328 3,672
Deaths Reported 5,142 1,014
Death Rate 16.4% 27.6%
Hospitalizations 12,268 1,407
Average Patient Age 61.2 yrs 60.8 yrs
% Female Patients 48.4% 48.5%
FDA Approval Date Apr 11, 2016 Nov 28, 2018
Manufacturer Hikma Pharmaceuticals USA Inc. Astellas Pharma US, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription